A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

NCT00961909 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: RO5095932
DRUG: RO5095932
DRUG: metformin
DRUG: placebo

Sponsor

Hoffmann-La Roche